相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo
Shuli Li et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Repurposing Auranofin, an Anti-Rheumatic Gold Compound, to Treat Acne Vulgaris by Targeting the NLRP3 Inflammasome
Gabsik Yang et al.
BIOMOLECULES & THERAPEUTICS (2020)
NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients
Sunny Malhotra et al.
BRAIN (2020)
Direct Binding to NLRP3 Pyrin Domain as a Novel Strategy to Prevent NLRP3-Driven Inflammation and Gouty Arthritis
Gabsik Yang et al.
ARTHRITIS & RHEUMATOLOGY (2020)
The NLRP3 Inflammasome as a Critical Actor in the Inflammaging Process
Maria Sebastian-Valverde et al.
CELLS (2020)
NLRP3-dependent microglial training impaired the clearance of amyloid-beta and aggravated the cognitive decline in Alzheimer's disease
Xiao-fei He et al.
CELL DEATH & DISEASE (2020)
The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer's disease
Niklas Lonnemann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Hepatic alterations associated with fine particulate matter exposure
Ivan Tavera Busso et al.
TOXICOLOGICAL RESEARCH (2020)
A novel small molecular NLRP3 inflammasome inhibitor alleviates neuroinflammatory response following traumatic brain injury
Ram Kuwar et al.
JOURNAL OF NEUROINFLAMMATION (2019)
MCC950 directly targets the NLRP3 ATP- hydrolysis motif for inflammasome inhibition
Rebecca C. Coll et al.
NATURE CHEMICAL BIOLOGY (2019)
Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis
Jaine L. S. Soares et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
Nathan Kelley et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Epigallocatechin-3-Gallate Prevents Acute Gout by Suppressing NLRP3 Inflammasome Activation and Mitochondrial DNA Synthesis
Hye Eun Lee et al.
MOLECULES (2019)
Multiple Sclerosis patients carry an increased burden of exceedingly rare genetic variants in the inflammasome regulatory genes
Lovro Vidmar et al.
SCIENTIFIC REPORTS (2019)
Inhibition of NLRP3 inflammasome in tumor microenvironment leads to suppression of metastatic potential of cancer cells
Hye Eun Lee et al.
SCIENTIFIC REPORTS (2019)
OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis
Alba Sanchez-Fernandez et al.
FRONTIERS IN IMMUNOLOGY (2019)
Microglia in Central Nervous System Inflammation and Multiple Sclerosis Pathology
Sofie Voet et al.
TRENDS IN MOLECULAR MEDICINE (2019)
Celastrol attenuates ox-LDL-induced mesangial cell proliferation via suppressing NLRP3 inflammasome activation
Zhenzhen Sun et al.
CELL DEATH DISCOVERY (2019)
Renal involvement in a silicosis patient - case report and literature review
Fei-Fei Chen et al.
RENAL FAILURE (2019)
NLRP3 Inflammasome Inhibitor Ameliorates Amyloid Pathology in a Mouse Model of Alzheimer's Disease
Jun Yin et al.
MOLECULAR NEUROBIOLOGY (2018)
The NLRP3 inflammasome in acute myocardial infarction
Stefano Toldo et al.
NATURE REVIEWS CARDIOLOGY (2018)
Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function
Jonathon P. Audia et al.
BASIC RESEARCH IN CARDIOLOGY (2018)
Tranilast directly targets NLRP3 to treat inflammasome-driven diseases
Yi Huang et al.
EMBO MOLECULAR MEDICINE (2018)
Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization
Jacob Fulp et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
OLT1177, a ß-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation
Carlo Marchetti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation
Gabsik Yang et al.
RHEUMATOLOGY (2018)
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
Hongbin He et al.
NATURE COMMUNICATIONS (2018)
Inflammasome Proteins As Biomarkers of Multiple Sclerosis
Robert W. Keane et al.
FRONTIERS IN NEUROLOGY (2018)
Anti-obesity potential of Glycyrrhiza uralensis and licochalcone A through induction of adipocyte browning
Hye Eun Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming
Jack P. Green et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Caspase-1 inhibition alleviates cognitive impairment and neuropathology in an Alzheimer's disease mouse model
Joseph Flores et al.
NATURE COMMUNICATIONS (2018)
Role of the NLRP3 inflammasome in cancer
Maryam Moossavi et al.
MOLECULAR CANCER (2018)
Licochalcone A attenuates acne symptoms mediated by suppression of NLRP3 inflammasome
Gabsik Yang et al.
PHYTOTHERAPY RESEARCH (2018)
NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway
Iva Hafner-Bratkovic et al.
NATURE COMMUNICATIONS (2018)
NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis
Carlo Marchetti et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Hyperactivation of the NLRP3 Inflammasome in Myeloid Cells Leads to Severe Organ Damage in Experimental Lupus
Ailing Lu et al.
JOURNAL OF IMMUNOLOGY (2017)
Oxidized phosphatidylcholine induces the activation of NLRP3 inflammasome in macrophages
Sang Hyeon Yeon et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders
Hua Jiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
S1PR1 on tumor-associated macrophages promotes lymphangiogenesis and metastasis via NLRP3/IL-1β
Benjamin Weichand et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Cutting Edge: TRAF6 Mediates TLR/IL-1R Signaling-Induced Nontranscriptional Priming of the NLRP3 Inflammasome
Yue Xing et al.
JOURNAL OF IMMUNOLOGY (2017)
Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer's disease
Carmen Venegas et al.
NATURE (2017)
CLICs-dependent chloride efflux is an essential and proximal upstream event for NLRP3 inflammasome activation
Tiantian Tang et al.
NATURE COMMUNICATIONS (2017)
P2X7 receptor and NLRP3 inflammasome activation in head and neck cancer
Ju Young Bae et al.
ONCOTARGET (2017)
Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases
Gabriele Fenini et al.
FRONTIERS IN PHARMACOLOGY (2017)
Interleukin-1 Blockade in Recently Decompensated Systolic Heart Failure Results From REDHART (Recently Decompensated Heart Failure Anakinra Response Trial)
Benjamin W. Van Tassell et al.
CIRCULATION-HEART FAILURE (2017)
Development and Characterization of a Hydroxyl-Sulfonamide Analogue, 5-Chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a Novel NLRP3 lnflammasome Inhibitor for Potential Treatment of Multiple Sclerosis
Chunqing Guo et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Amyloid beta: structure, biology and structure-based therapeutic development
Guo-fang Chen et al.
ACTA PHARMACOLOGICA SINICA (2017)
Propagation of tau pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
Jada Lewis et al.
ACTA NEUROPATHOLOGICA (2016)
NLRP3 inflammasome signaling is activated by low-level lysosome disruption but inhibited by extensive lysosome disruption: roles for K+ efflux and Ca2+ influx
Michael A. Katsnelson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2016)
Inflammasome-Dependent Induction of Adaptive NK Cell Memory
Jasper G. van den Boorn et al.
IMMUNITY (2016)
Inflammation as a Driver of Adverse Left Ventricular Remodeling After Acute Myocardial Infarction
Peter C. Westman et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Activation of NLRP3 inflammasome enhances the proliferation and migration of A549 lung cancer cells
Yanli Wang et al.
ONCOLOGY REPORTS (2016)
Late-Onset Cryopyrin-Associated Periodic Syndrome Due to Myeloid-Restricted Somatic NLRP3 Mosaicism
Anna Mensa-Vilaro et al.
Arthritis & Rheumatology (2016)
A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet
Gabsik Yang et al.
SCIENTIFIC REPORTS (2016)
Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: a novel strategy to treat acute gout
Hye Eun Lee et al.
SCIENTIFIC REPORTS (2016)
NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins
Afrasyab Altaf et al.
CORONARY ARTERY DISEASE (2015)
Current treatment recommendations and considerations for cryopyrin-associated periodic syndrome
Isabelle Kone-Paut et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2015)
NLRP3 rs35829419 polymorphism is associated with increased susceptibility to multiple diseases in humans
Q. Zhang et al.
GENETICS AND MOLECULAR RESEARCH (2015)
K+ Efflux Agonists Induce NLRP3 Inflammasome Activation Independently of Ca2+ Signaling
Michael A. Katsnelson et al.
JOURNAL OF IMMUNOLOGY (2015)
The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
Yun-Hee Youm et al.
NATURE MEDICINE (2015)
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
Rebecca C. Coll et al.
NATURE MEDICINE (2015)
Tranilast: A review of its therapeutic applications
Sara Darakhshan et al.
PHARMACOLOGICAL RESEARCH (2015)
The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine
L. Baron et al.
CELL DEATH & DISEASE (2015)
K+ regulates Ca2+ to drive inflammasome signaling: dynamic visualization of ion flux in live cells
J. R. Yaron et al.
CELL DEATH & DISEASE (2015)
NLRP3 inflammasome: From a danger signal sensor to a regulatory node of oxidative stress and inflammatory diseases
Amna Abderrazak et al.
REDOX BIOLOGY (2015)
Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu
M. Niebuhr et al.
ALLERGY (2014)
Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment
Rebeccah J. Mathews et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Suppression of the pro-inflammatory NLRP3/interleukin-1β pathway in macrophages by the thioredoxin reductase inhibitor auranofin
Elina Isakov et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2014)
Genetic variations of NLRP1: susceptibility in psoriasis
A. -K. Ekman et al.
BRITISH JOURNAL OF DERMATOLOGY (2014)
The inflammasome and lupus: another innate immune mechanism contributing to disease pathogenesis?
J. Michelle Kahlenberg et al.
CURRENT OPINION IN RHEUMATOLOGY (2014)
NLRP3 Inflammasome as a Novel Player in Myocardial Infarction
Masafumi Takahashi
INTERNATIONAL HEART JOURNAL (2014)
Safety, tolerability, pharmacokinetics, and pharmacodynamics of single-dose anti-interleukin-18 mAb GSK1070806 in healthy and obese subjects
Prafull Mistry et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS (2014)
3,4-Methylenedioxy-β-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome
Yuan He et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
A Novel Pharmacologic Inhibitor of the NLRP3 Inflammasome Limits Myocardial Injury After Ischemia-Reperfusion in the Mouse
Carlo Marchetti et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2014)
Cytosolic Double-Stranded RNA Activates the NLRP3 Inflammasome via MAVS-Induced Membrane Permeabilization and K+ Efflux
Luigi Franchi et al.
JOURNAL OF IMMUNOLOGY (2014)
Propionibacterium acnes Activates the NLRP3 Inflammasome in Human Sebocytes
Zheng Jun Li et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
IL-1β Drives Inflammatory Responses to Propionibacterium acnes In Vitro and In Vivo
Magdalena Kistowska et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
NLRP3 inflammasome activation is required for fibrosis development in NAFLD
Alexander Wree et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2014)
Deregulated NLRP3 and NLRP1 Inflammasomes and Their Correlations with Disease Activity in Systemic Lupus Erythematosus
Qingrui Yang et al.
JOURNAL OF RHEUMATOLOGY (2014)
The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation
Bernardo S. Franklin et al.
NATURE IMMUNOLOGY (2014)
Human NLRP3 inflammasome senses multiple types of bacterial RNAs
Wenwen Sha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
The role of p2x7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases
Robson Coutinho-Silva et al.
Biomedical Journal (2014)
A novel benzo[d]imidazole derivate prevents the development of dextran sulfate sodium-induced murine experimental colitis via inhibition of NLRP3 inflammasome
Wen Liu et al.
BIOCHEMICAL PHARMACOLOGY (2013)
The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemiareperfusion injury
Oystein Sandanger et al.
CARDIOVASCULAR RESEARCH (2013)
The Adaptor MAVS Promotes NLRP3 Mitochondrial Localization and Inflammasome Activation
Naeha Subramanian et al.
CELL (2013)
Upregulated NLRP3 Inflammasome Activation in Patients With Type 2 Diabetes
Hye-Mi Lee et al.
DIABETES (2013)
Omega-3 Fatty Acids Prevent Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome Activation
Yiqing Yan et al.
IMMUNITY (2013)
K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
Raul Munoz-Planillo et al.
IMMUNITY (2013)
The complement membrane attack complex triggers intracellular Ca2+ fluxes leading to NLRP3 inflammasome activation
Kathy Triantafilou et al.
JOURNAL OF CELL SCIENCE (2013)
The Mitochondrial Antiviral Protein MAVS Associates with NLRP3 and Regulates Its Inflammasome Activity
Sangjun Park et al.
JOURNAL OF IMMUNOLOGY (2013)
Genetic Variation in the Inflammasome and Atopic Dermatitis Susceptibility
Cecilia Bivik et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
被撤回的出版物: Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway (Retracted article. See vol. 16, pg. 7873, 2017)
Aiguo Liu et al.
MOLECULAR MEDICINE REPORTS (2013)
NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice
Michael T. Heneka et al.
NATURE (2013)
Evidences of the inflammasome pathway in chronic prostatitis and chronic pelvic pain syndrome in an animal model
Chih-Shou Chen et al.
PROSTATE (2013)
Treating inflammation by blocking interleukin-1 in humans
Charles A. Dinarello et al.
SEMINARS IN IMMUNOLOGY (2013)
Parthenolide generates reactive oxygen species and autophagy in MDA-MB231 cells. A soluble parthenolide analogue inhibits tumour growth and metastasis in a xenograft model of breast cancer
A. D'Anneo et al.
CELL DEATH & DISEASE (2013)
Effects of Gevokizumab on Glycemia and Inflammatory Markers in Type 2 Diabetes
Claudia Cavelti-Weder et al.
DIABETES CARE (2012)
Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility
Maria Carlstrom et al.
EXPERIMENTAL DERMATOLOGY (2012)
Oxidized Mitochondrial DNA Activates the NLRP3 Inflammasome during Apoptosis
Kenichi Shimada et al.
IMMUNITY (2012)
Redox control of NLRP3 inflammasome activation in health and disease
Anna Rubartelli
JOURNAL OF LEUKOCYTE BIOLOGY (2012)
Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis
Laura J. Dixon et al.
LABORATORY INVESTIGATION (2012)
Critical role for calcium mobilization in activation of the NLRP3 inflammasome
Tomohiko Murakami et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study
H. Ralph Schumacher et al.
ARTHRITIS CARE & RESEARCH (2012)
Biochemistry of Amyloid β-Protein and Amyloid Deposits in Alzheimer Disease
Colin L. Masters et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: Rationale and Design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)
Paul M. Ridker et al.
AMERICAN HEART JOURNAL (2011)
The NLRP3 inflammasome in health and disease: the good, the bad and the ugly
P. Menu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Epigallocatechin-3-gallate prevents lupus nephritis development in mice via enhancing the Nrf2 antioxidant pathway and inhibiting NLRP3 inflammasome activation
Pei-Yi Tsai et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Mite allergen is a danger signal for the skin via activation of inflammasome in keratinocytes
Xiuju Dai et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
A role for mitochondria in NLRP3 inflammasome activation
Rongbin Zhou et al.
NATURE (2011)
Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Haitao Wen et al.
NATURE IMMUNOLOGY (2011)
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Bolormaa Vandanmagsar et al.
NATURE MEDICINE (2011)
Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study
Isabelle Kone-Paut et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Type 2 diabetes as an inflammatory disease
Marc Y. Donath et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Dina G. Tiniakos et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
Pattern Recognition Receptors and Inflammation
Osamu Takeuchi et al.
CELL (2010)
The Inflammasome-Mediated Caspase-1 Activation Controls Adipocyte Differentiation and Insulin Sensitivity
Rinke Stienstra et al.
CELL METABOLISM (2010)
Canakinumab: a human anti-IL-1β monoclonal antibody for the treatment of cryopyrin-associated periodic syndromes
Leigh D. Church et al.
EXPERT REVIEW OF CLINICAL IMMUNOLOGY (2010)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis
Md. Hasan Zaki et al.
IMMUNITY (2010)
Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the Inflammasome
Christine Juliana et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
Peter Duewell et al.
NATURE (2010)
Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1 beta in type 2 diabetes
Seth L. Masters et al.
NATURE IMMUNOLOGY (2010)
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Seth L. Masters et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
Inflammatory Arthritis in Caspase 1 Gene-Deficient Mice Contribution of Proteinase 3 to Caspase 1-Independent Production of Bioactive Interleukin-1β
Leo A. B. Joosten et al.
ARTHRITIS AND RHEUMATISM (2009)
Function of Nod-like receptors in microbial recognition and host defense
Luigi Franchi et al.
IMMUNOLOGICAL REVIEWS (2009)
Vinyl Sulfones as Antiparasitic Agents and a Structural Basis for Drug Design
Iain D. Kerr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Fungal Zymosan and Mannan Activate the Cryopyrin Inflammasome
Mohamed Lamkanfi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Glyburide inhibits the Cryopyrin/Nalp3 inflammasome
Mohamed Lamkanfi et al.
JOURNAL OF CELL BIOLOGY (2009)
Cutting Edge: NF-κB Activating Pattern Recognition and Cytokine Receptors License NLRP3 Inflammasome Activation by Regulating NLRP3 Expression
Franz G. Bauernfeind et al.
JOURNAL OF IMMUNOLOGY (2009)
Involvement of the NLRP3 Inflammasome in Innate and Humoral Adaptive Immune Responses to Fungal β-Glucan
Himanshu Kumar et al.
JOURNAL OF IMMUNOLOGY (2009)
Randomized controlled trial design in rheumatoid arthritis: the past decade
Vibeke Strand et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE(2) production in macrophages
Shinha Han et al.
ARCHIVES OF PHARMACAL RESEARCH (2008)
Familial cold auto-inflammatory syndrome (FCAS): characterization of symptomatology and impact on patients' lives
Beate Stych et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization
Veit Hornung et al.
NATURE IMMUNOLOGY (2008)
The NALP3 inflammasome is involved in the innate immune response to amyloid-β
Annett Halle et al.
NATURE IMMUNOLOGY (2008)
Genetic variation in proteins of the cryopyrin inflammasome influences susceptibility and severity of rheumatoid arthritis (The Swedish TIRA project)
A. Kastbom et al.
RHEUMATOLOGY (2008)
The activity of caspase-1 is increased in lesional psoriatic epidermis
Claus Johansen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
(S)-1-((S)-2-{[1-(4-amino-3-chloro-phenyl)-methanoyl]-amino}-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide (VX-765), an orally available selective interleukin (IL)-converting enzyme/caspase-1 inhibitor, exhibits potent anti-inflammatory activities by inhibiting the release of IL-1β and IL-18
Woods Wannamaker et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Interleukin-1-receptor antagonist in type 2 diabetes mellitus
Claus M. Larsen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages
Cristiane M. Cruz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So et al.
ARTHRITIS RESEARCH & THERAPY (2007)
Caspase-1-dependent pore formation during pyroptosis leads to osmotic lysis of infected host macrophages
Susan L. Fink et al.
CELLULAR MICROBIOLOGY (2006)
Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival
Laure Gurcel et al.
CELL (2006)
The P2X7 receptor:: A key player in IL-1 processing and release
Davide Ferrari et al.
JOURNAL OF IMMUNOLOGY (2006)
Gout-associated uric acid crystals activate the NALP3 inflammasome
F Martinon et al.
NATURE (2006)
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite
M Platten et al.
SCIENCE (2005)
Apoptosis-based therapies and drug targets
U Fischer et al.
CELL DEATH AND DIFFERENTIATION (2005)
Caspase inhibitors: A pharmaceutical industry perspective
SD Linton
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2005)
Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P-acnes GroEL
GM Graham et al.
BRITISH JOURNAL OF DERMATOLOGY (2004)
IL-18 in patients with multiple sclerosis
J Losy et al.
ACTA NEUROLOGICA SCANDINAVICA (2001)
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
EM El-Omar et al.
NATURE (2000)
分享论文
